Chronic Total Occlusion (CTO) System
The only U.S. approved crossing and re-entry systems currently indicated for use in coronary CTOs.
The CrossBoss® Catheter, Stingray® Catheter, and Stingray Guidewire facilitate the intraluminal placement of conventional guidewires beyond stenotic coronary lesions (including CTOs).
Safe & Effective
The FAST-CTOs trial1 demonstrated that the CTO System is safe and effective in the treatment of coronary chronic total occlusions.
Reduced Procedure Times
Procedure time with the CTO System is shorter, with lower fluoroscopy times, compared to historical controls1.
Provides Treatment Alternatives
May allow patients to avoid coronary artery bypass graft surgery (CABG).
 |
The CrossBoss Coronary Catheter is designed to quickly and safely deliver a guidewire via true lumen or subintimal pathways. Discover more about the CrossBoss Catheter » |
 |
The Stingray Coronary System (catheter and guidewire) is designed to accurately target and re-enter the true lumen from a subintimal position. Discover more about the Stingray System » |
1Whitlow et al, J AM Coll Cardiol Intv. 2012;5(4):393-401
Prior to use, please see the complete "Directions for Use" for more information on Indications, Contraindications, Warnings, Precautions, Adverse Events, and Operator's Instructions.
View CrossBoss Catheter Prescriptive Information »
View Stingray Catheter, and Stingray® Guidewire Prescriptive Information »
View Stingray Catheter, and Stingray® Guidewire Prescriptive Information »
PROMUS Element is an unregistered trademark of Boston Scientific Corporation or its affiliates. All other trademarks are the property of their respective owners.
IC-115504-AA OCT2012
